TECX Tectonic Therapeutic, Inc. Common Stock Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
16:08
Aug 26
Aug 26
Author compares street vs retail biotech top lists and notes RVMD approval with pricing.
Author compares street vs retail biotech top lists and notes RVMD approval with pricing expectations, but frames all names as observational research rather than personal positions.
LOW
17:25
Mar 29
Mar 29
The author questions the clinical efficacy and dose-response data of Merck's sotatercept.
The author questions the clinical efficacy and dose-response data of Merck's sotatercept, suggesting potential overvaluation.
11:31
Feb 10
Feb 10
Short TECX as AZN's pipeline removal of their relaxin mAb signals class-level concern.
Short TECX as AZN's pipeline removal of their relaxin mAb signals class-level concern or validation failure, which the author reads as a direct negative catalyst for TECX's relaxin program.
HIGH
About TECX Analyst Coverage
Buzzberg tracks TECX (Tectonic Therapeutic, Inc. Common Stock) across 2 sources. 0 bullish vs 1 bearish calls from 2 analysts. Sentiment: mixed to bearish. 3 total trade ideas tracked. Latest voices: seedy19tron, A May MD.